A medical records based study for Di'ao Xinxuekang Capsules in the treatment of angina pectoris of coronary heart disease
Not Applicable
- Conditions
- angina pectoris of coronary heart disease
- Registration Number
- ITMCTR2200005554
- Lead Sponsor
- Guangzhou Panyu Central Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1) From January 1, 2011 to December 31, 2021, patients with coronary heart disease who were prescribed Di'ao Xinxuekang Capsules for the first time, or were prescribed Di'ao Xinxuekang Capsules again after at least 30 days of drug withdrawal;
2) Followed the doctor's orders to take medicine, had at least one hospital visit record during taking Di'ao Xinxuekang Capsules, and the interval between the return visit and the initial visit was at least 1 year;
3) Gender and age were not limited.
Exclusion Criteria
1) Cases are considered to affect the evaluation of Di'ao Xinxuekang Capsules and are not suitable for collection.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of major adverse cardiovascular events;Laboratory metrics;Interval between readmissions for coronary heart disease;Seattle angina questionnaire;Indicators of echocardiography;Indicators of twelve-lead ECG;
- Secondary Outcome Measures
Name Time Method